Proshares Ultra Nasdaq Biotechnology Etf logo

Proshares Ultra Nasdaq Biotechnology Etf(BIB)

$62.27-2.67%

Market is closed - opens 7 PM, 09 Sep 2024

Insights

  • Proshares Ultra Nasdaq Biotechnology Etf is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Proshares Ultra Nasdaq Biotechnology Etf stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Proshares Ultra Nasdaq Biotechnology Etf stock is Range bound.
  • Based on analysis of the Pivot Points, the current market trend for Proshares Ultra Nasdaq Biotechnology Etf stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
45.34
Neutral
Stochastic
8.65, 28.6
Neutral
Ultimate Oscillator
43.15
Neutral
Stochastic Relative Strength Index
2.3, 30.63
Neutral
Moving Average Convergence Divergence
0.55, 0.82
Sell

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
66.39
Buy
20
65.14
Buy
50
64.1
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
65.69
Buy
20
65.41
Buy
50
63.73
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
66.31
Sell
20
65.01
Neutral
50
64.47
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
65.63
Sell
20
66.22
Sell
50
66.72
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
64.97
Sell
20
65.96
Sell
50
66.84
Sell

Pivot

Pivot

Value

Resistance L3
66.75
Resistance L2
66.01
Resistance L1
65.47
Pivot Point
64.73
Support L1
64.19
Support L2
63.45
Support L3
62.91

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.